Neurocrine Bioscience buy Barclays PLC
Start price
02.08.24
/
50%
€139.00
Target price
02.08.25
€164.74
Performance (%)
-20.29%
End price
03.08.25
€110.80
Summary
This prediction ended on 03.08.25 with a price of €110.80. The prediction for Neurocrine Bioscience disappointed with a performance of -20.29%. Barclays_PLC has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -1.577% | -1.577% | 8.571% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by Barclays_PLC for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Barclays PLC from $169.00 to $180.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.85
23.12.24
23.12.24
€158.60
23.12.25
23.12.25
0.96%
15.12.25
15.12.25
Stopped prediction by Barclays_PLC for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€109.95
09.09.24
09.09.24
€144.91
09.09.25
09.09.25
10.87%
10.09.25
10.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€131.25
02.05.24
02.05.24
€157.54
02.05.25
02.05.25
-26.05%
03.05.25
03.05.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.15
23.01.24
23.01.24
€137.96
23.01.25
23.01.25
8.44%
24.01.25
24.01.25